Publications:

Publications:

  1. A Coloured Pen Needle Education System Improves Insulin Site Rotation Habits: Results of a Randomized Study.

Berard LD, Pockett SA, Roscoe RS, Siemens RL.

Diabetes Ther. 2020 Dec;11(12):2979-2991. doi: 10.1007/s13300-020-00939-2. Epub 2020 Oct 16.

  1. 2. FIT Forum for Injection Technique Canada:Recommendations for Best Practice in Injection

Technique. 4th ed. 2020.

Berard L, Delorme-Goulet C, Hagerty D, MacNeill G, Roscoe R.

Available at:  https://www.fit4diabetes.com/canada-english/fit-

recommendations/Accessed April 5, 2021

  1. Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review.

Woo V, Berard L, Roscoe R.

Diabetes Ther. 2020 Nov;11(11):2539-2553. doi: 10.1007/s13300-020-00915-w. Epub 2020 Sep 17.

  1. Complementary and Alternative Medicine for Diabetes.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Grossman LD, Roscoe R, Shack AR.

Can J Diabetes. 2018 Apr;42 Suppl 1:S154-S161. doi: 10.1016/j.jcjd.2017.10.023.

  1. Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes.

Berard L, Antonishyn N, Arcudi K, Blunden S, Cheng A, Goldenberg R, Harris S, Jones S, Mehan U, Morrell J, Roscoe R, Siemens R, Vallis M, Yale JF.

Diabetes Ther. 2018 Apr;9(2):501-519. doi: 10.1007/s13300-018-0375-7. Epub 2018 Feb 23.

Abstract

It is currently estimated that 11 million Canadians are living with diabetes or prediabetes. Although hyperglycemia is associated with serious complications, it is well established that improved glycemic control reduces the risk of microvascular complications and can also reduce cardiovascular (CV) complications over the long term. The UKPDS and ADVANCE landmark trials have resulted in diabetes guidelines recommending an A1C target of ≤ 7.0% for most patients or a target of ≤ 6.5% to further reduce the risk of nephropathy and retinopathy in those with type 2 diabetes (T2D), if it can be achieved safely. However, half of the people with T2D in Canada are not achieving these glycemic targets, despite advances in diabetes pharmacological management. There are many contributing factors to account for this poor outcome; however, one of the major factors is the delay in treatment advancement, particularly a resistance to insulin initiation and intensification. To simplify the process of initiating and titrating insulin in T2D patients, a group of Canadian experts reviewed the evidence and best clinical practices with the goal of providing guidance and practical recommendations to the diabetes healthcare community at large. This expert panel included general practitioners (GPs), nurses, nurse practitioners, endocrinologists, dieticians, pharmacists, and a psychologist. This article summarizes the panel recommendation

  1. 6. Organization of diabetes care.

Can J Diabetes. 2013 Apr;37 Suppl 1:S20-5. doi: 10.1016/j.jcjd.2013.01.014. Epub 2013 Mar 26.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Clement M, Harvey B, Rabi DM, Roscoe RS, Sherifali D.

7.Revisiting the Role of a Diabetes Educator: An Opportunity Not to Be Missed

Can J Diabetes. 2012 Aug;36 157-158. DOI: https://doi.org/10.1016/j.jcjd.2012.07.010

Diana Sherifali, RN, PhD, CDEa,∗,Correspondence information about the author RN, PhD, CDE Diana SherifaliEmail the author RN, PhD, CDE Diana Sherifali

Anne Belton, RN, MDE, CDEb,, Lori Berard, RN, CDEc,Catherine Freeze, MEd, RD, CDEd,Helen Jones, RN, MSN, CDEe,Robert Roscoe, BSc Pharm, ACPR, CDE, CPTf

 The Pharmacists Role in Injectable Diabetes Therapy

CCCEP Program # 1065-2014-1059-I-P  2014 July   Roscoe RS.

  1. The Evolving Role of the Pharmacist in Diabetes Care:” A Work in Progress

Canadian Diabetes. 2011 Winter;24 4:10-11 3 , Roscoe RS.

  1. Treating the Common Cold & Type 2 Diabetes

Diabetes Care.2010 Winter;44 4:20-24 , Roscoe RS

Conference abstract and Posters:

Poster presented at ADECS20(Association of Diabetes Care & Education Specialists) 2020

 “Pharmacists are an Untapped and Pragmatic Resource to Optimize Insulin Injection Practices”

 Lori D Berard,1 Sherri A Pockett,2 Robert S Roscoe,3 Rick L Siemans4

1Nurse Consultant Winnipeg, MB; 2St Boniface General Hospital, Winnipeg, MB;

3Diabetes Education Centre, Saint John Regional Hospital, Saint John, NB; 4London Drugs Pharmacy, Lethbridge, AB

Featured Poster at Diabetes Canada Winnipeg  2019.

 Abstract 33 – The mCPN Intervention Study: Optimizing Insulin Technique With a Coloured Pen Needle Education System

Berard LD, Pockett SA, Roscoe RS, Siemans RL.

Can J Diabetes. 2019 Oct;43 Suppl: S14. doi: 10.1016/j.jcjd.2019.07.041